STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.
STOCK OPTION GRANTStock Option Grant • November 27th, 2017 • Opiant Pharmaceuticals, Inc. • Metal mining
Contract Type FiledNovember 27th, 2017 Company IndustryReference is hereby made to (i) the Stock Option Plan of Lightlake Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”), and (ii) the Director Agreement dated December 31, 2012, between the Company and Geoffrey Wolf (as amended, restated, or otherwise modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed to them in the Stock Option Plan unless otherwise defined herein or in the Letter.